| Fourteenth Patient Dosed in Neuralstem ALS Stem Cell Trial Citybizlist (press release) ... the second patient to receive stem cells in the cervical (upper back) region of the spine was dosed on February 29th in the ongoing Phase I trial of its spinal cord neural stem cells in amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease). See all stories on this topic » |
No comments:
Post a Comment